1. Combined Inhibition of Tumor Necrosis Factor α and Interleukin‐17 As a Therapeutic Opportunity in Rheumatoid Arthritis: Development and Characterization of a Novel Bispecific Antibody. Issue 1 (January 2015) Authors: Fischer, Jens A. A.; Hueber, Axel J.; Wilson, Stacy; Galm, Margarete; Baum, Wolfgang; Kitson, Christopher; Auer, Johannes; Lorenz, Stefan H.; Moelleken, Jörg; Bader, Martin; Tissot, Alain C.; Tan, Seng‐Lai; Seeber, Stefan; Schett, Georg Journal: Arthritis & rheumatology Issue: Volume 67:Issue 1(2015) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Sca‐1 expression defines developmental stages of mouse pDCs that show functional heterogeneity in the endosomal but not lysosomal TLR9 response. Issue 11 (27th August 2013) Authors: Niederquell, Marina; Kurig, Stefanie; Fischer, Jens A. A.; Tomiuk, Stefan; Swiecki, Melissa; Colonna, Marco; Johnston, Ian C. D.; Dzionek, Andrzej Journal: European journal of immunology Issue: Volume 43:Issue 11(2013:Nov.) Page Start: 2993 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗